XML 55 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Schedule of Activity Related to Warrants

BioTime has issued equity-classified warrants to purchase its common shares. Activity related to warrants in 2017, 2016, and 2015 is presented in the table below (in thousands, except price per share):

 

   

Number of

Warrant

Shares

   

Per Share

Exercise

Price

   

Weighted

Average

Exercise

Price

 
Outstanding, January 1, 2015     9,195     $ 5.00     $ 5.00  
Exercised in 2015     (4)       5.00       5.00  
Warrant adjustment (1)     919                  
Outstanding, December 31, 2015     10,110     $ 4.55     $ 4.55  
Expired in 2016     (715)       4.55       4.55  
Outstanding, December 31, 2016     9,395     $ 4.55     $ 4.55  
Expired in 2017     -                  
Outstanding, December 31, 2017 (2)     9,395     $ 4.55     $ 4.55  

 

  (1) The number of shares issuable upon the exercise of the warrants was adjusted as a result of the distribution of OncoCyte common stock to BioTime shareholders during December 2015.
     
  (2) The 9,394,862 outstanding warrants will expire, if unexercised, beginning June 5, 2018 through September 30, 2018.